The latest announcement is out from Corbion NV ( (NL:CRBN) ).
Corbion NV reported strong financial results for 2024, with a significant improvement in sales and adjusted EBITDA, and a notable increase in free cash flow. The company completed the divestment of its emulsifiers business and started operations at its lactic acid plant in Thailand. Despite a slight decline in sales for its Functional Ingredients & Solutions division due to pricing pressures, Corbion saw robust growth in its Health & Nutrition segment, particularly in the Nutrition business, which contributed to an 84.1% increase in adjusted EBITDA. The company proposed a 5% dividend increase, reflecting confidence in its future performance.
More about Corbion NV
Corbion NV is an Amsterdam-listed company specializing in sustainable ingredients, with a focus on preservation through scientific applications. The company operates in the food and nutrition sectors, offering products such as dairy stabilizers, natural antioxidants, mold inhibitors, and dough conditioners, and serves markets including aquaculture and pet food.
YTD Price Performance: 7.45%
Average Trading Volume: 4,582
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €1.34B
For an in-depth examination of CRBN stock, go to TipRanks’ Stock Analysis page.